Avanir Pharmaceuticals

Avanir Pharmaceuticals company information, Employees & Contact Information

Every day, we bring a singular focus to the research and development of groundbreaking pharmaceutical treatments for people with central nervous system (CNS) conditions. Our mission is delivering innovative CNS solutions to improve the lives of patients and their care communities. When there’s a patient, caregiver or provider in need — we’ll protect! When there’s a call for innovative treatment solutions — we’ll answer! When there’s a CNS case that seems unsolvable — we’ll challenge! It’s who we are — we’re fighters. It’s why we’re here. We are Avanir.

Company Details

Employees
136
Founded
-
Address
30 Enterprise,
Phone
(194) 938-9670
Email
bi****@****nir.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
avanir.com
HQ
Aliso Viejo, CA
Looking for a particular Avanir Pharmaceuticals employee's phone or email?

Avanir Pharmaceuticals Questions

News

Avanir Pharmaceuticals Joins California Life Sciences - PR Newswire

Avanir Pharmaceuticals Joins California Life Sciences PR Newswire

Drugmaker that targeted dementia patients to pay $116 million - CNN

Drugmaker that targeted dementia patients to pay $116 million CNN

Avanir Joins Decentralized Trials & Research Alliance (DTRA) as a Founding Member to Advance Access to Clinical Trials - PR Newswire

Avanir Joins Decentralized Trials & Research Alliance (DTRA) as a Founding Member to Advance Access to Clinical Trials PR Newswire

Avanir marketing chief on selling first-in-class therapies - Medical Marketing and Media

Avanir marketing chief on selling first-in-class therapies Medical Marketing and Media

Patent cliff ahead: Otsuka to buy Avanir for $3.5B and a slate of new products - BioPharma Dive

Patent cliff ahead: Otsuka to buy Avanir for $3.5B and a slate of new products BioPharma Dive

AG Yost Announces $103 Million Multistate Settlement with Avanir Pharmaceuticals - Ohio Attorney General (.gov)

AG Yost Announces $103 Million Multistate Settlement with Avanir Pharmaceuticals Ohio Attorney General (.gov)

Avanir Reports Phase 3 Data of AVP-786 for Agitation in Alzheimer Disease - NeurologyLive

Avanir Reports Phase 3 Data of AVP-786 for Agitation in Alzheimer Disease NeurologyLive

Otsuka's Avanir unit plots 140 layoffs in wake of $116M Nuedexta settlement - Fierce Pharma

Otsuka's Avanir unit plots 140 layoffs in wake of $116M Nuedexta settlement Fierce Pharma

Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals For $3.5 Billion - BioSpace

Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals For $3.5 Billion BioSpace

Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing Home Residents to Pay Over $115 Million - Center for Medicare Advocacy

Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing Home Residents to Pay Over $115 Million Center for Medicare Advocacy

Former Avanir drug sales representative pleads guilty to kickbacks scheme - Reuters

Former Avanir drug sales representative pleads guilty to kickbacks scheme Reuters

Avanir Pharmaceuticals Announces FDA Approval of ONZETRA - MultiVu

Avanir Pharmaceuticals Announces FDA Approval of ONZETRA MultiVu

Avanir Pharmaceuticals Named One of Orange County's Best Places to Work - PR Newswire

Avanir Pharmaceuticals Named One of Orange County's Best Places to Work PR Newswire

Otsuka's Avanir agrees to pay $116M over Nuedexta kickbacks probe - Fierce Pharma

Otsuka's Avanir agrees to pay $116M over Nuedexta kickbacks probe Fierce Pharma

City of Los Angeles opens investigation into drugmaker following CNN report - CNN

City of Los Angeles opens investigation into drugmaker following CNN report CNN

University of California Irvine's Paul Merage School of Business Announces Avanir Pharmaceuticals CEO and CFO Join Advisory Board of Center for Health Care Management and Policy - PR Newswire

University of California Irvine's Paul Merage School of Business Announces Avanir Pharmaceuticals CEO and CFO Join Advisory Board of Center for Health Care Management and Policy PR Newswire

Avanir Pharmaceuticals, Inc. to Continue Clinical Development of Investigational AVP-786 for the Treatment of Agitation in Patients with Alzheimer's Dementia - PR Newswire

Avanir Pharmaceuticals, Inc. to Continue Clinical Development of Investigational AVP-786 for the Treatment of Agitation in Patients with Alzheimer's Dementia PR Newswire

Avanir Pharmaceuticals Announces Resolution of Government Investigation - PR Newswire

Avanir Pharmaceuticals Announces Resolution of Government Investigation PR Newswire

Avanir Pharmaceuticals Initiates Phase II Study to Evaluate AVP-786 for Treatment of Neurobehavioral Disinhibition Associated with Traumatic Brain Injury - PR Newswire

Avanir Pharmaceuticals Initiates Phase II Study to Evaluate AVP-786 for Treatment of Neurobehavioral Disinhibition Associated with Traumatic Brain Injury PR Newswire

Avanir Pharmaceuticals Appoints Richard Malamut, MD, as Senior Vice President, Research & Development, and Chief Medical Officer - PR Newswire

Avanir Pharmaceuticals Appoints Richard Malamut, MD, as Senior Vice President, Research & Development, and Chief Medical Officer PR Newswire

Otsuka expands CNS presence with Avanir purchase - PMLiVE

Otsuka expands CNS presence with Avanir purchase PMLiVE

Japan’s Otsuka to Buy Avanir Pharmaceuticals - The Wall Street Journal

Japan’s Otsuka to Buy Avanir Pharmaceuticals The Wall Street Journal

Did Avanir overmarket its brain drug to the elderly? - Fierce Pharma

Did Avanir overmarket its brain drug to the elderly? Fierce Pharma

Avanir shelves Danny Glover PBA awareness ad in favor of branded Nuedexta effort - Fierce Pharma

Avanir shelves Danny Glover PBA awareness ad in favor of branded Nuedexta effort Fierce Pharma

Otsuka expects to shell out $120M to settle Avanir's Nuedexta marketing probe - Fierce Pharma

Otsuka expects to shell out $120M to settle Avanir's Nuedexta marketing probe Fierce Pharma

Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion - Los Angeles Times

Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion Los Angeles Times

Avanir Pharmaceuticals Inc. (AVNR) Soared To A New High On Study Results - RTTNews

Avanir Pharmaceuticals Inc. (AVNR) Soared To A New High On Study Results RTTNews

AVANIR Pharma Q1 Loss Narrows - Quick Facts - RTTNews

AVANIR Pharma Q1 Loss Narrows - Quick Facts RTTNews

Ex-pharmacy rep sentenced to prison for paying kickbacks to Cleveland doctors - Cleveland.com

Ex-pharmacy rep sentenced to prison for paying kickbacks to Cleveland doctors Cleveland.com

Emergent BioSolutions Closes Purchase Of Group Of Anthrax Monoclonal Antibodies From AVANIR Pharma - Quick Facts - RTTNews

Emergent BioSolutions Closes Purchase Of Group Of Anthrax Monoclonal Antibodies From AVANIR Pharma - Quick Facts RTTNews

Top Avanir Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant